Riccardo Canevari
Chief Executive Officer RadioPharm Theranostics
Seminars
Wednesday 22nd July 2026
Linking Imaging of Brain Metastases to Patient Treatment & Change of Management for Novel Theranostic Strategies
11:00 am
- Demonstrating strong tumor uptake and imaging performance in Trop-2–positive cancers
- Highlighting opportunities to use Trop-2 expression for patient selection and treatment planning
- Establishing Trop-2 as a promising candidate for integrated diagnostic and therapeutic strategies
Wednesday 22nd July 2026
Integrating Imaging‑Derived Dosimetry & Target Confirmation to Optimize Therapeutic First‑in‑Human Study Design
1:30 pm
- Translating diagnostic imaging biodistribution into therapeutic dose estimates and dosimetry thresholds for cycle scheduling
- Defining target expression and on-target binding criteria via pre-treatment scans to guide patient selection and reduce off-target risk
- Planning treatment cycles and follow-up intervals based on calculated organ dose limits, expected adverse-event kinetics, and recovery profiles
